Skip to main content
. 2006 Jul 20;6:66. doi: 10.1186/1471-2180-6-66

Table 1.

Predicted functional motifs for ORF1-ORF14 of B. cenocepacia

RND CONSERVED MOTIFS FUNCTIONAL MOTIFS STRUCTURAL ANALYSIS

ORFsa Motif s Ab, Bb, Cb, Db Acriflavin resistance protein domains (ACRIFLAVINRP)c AcrB transmembrane domainc AcrB pore domain (PN1, PN2, PC1, PC2 subdomains)c AcrB/TolC docking domain (DN, DC subdomains)c Familyd
BCAS0592 ORF1 Chromosome 3 38–134, 445–493, 826–1051, 272–503 8–32, 36–54, 336–359, 363–384, 391–415, 445–468, 470–493, 552–569, 620–634 272–503, 826–1051 38–134, 565–669 182–271, 720–825 Multidrug efflux transporter AcrB pore domain
BCAS0765 ORF2 Chromosome 3 38–134, 445–493, 809–1035, 272–503 8–32, 36–54, 336–359, 363–384, 391–415, 445–468, 470–493, 553–570, 622–636 272–503, 809–1035 38–134, 566–672 182–271, 723–808 Multidrug efflux transporter AcrB transmembrane domain
BCAL1675 ORF3 Chromosome 1 38–133, 444–492, 804–1027, 271–502 8–32, 36–54, 335–358, 362–383, 390–414, 444–467, 469–492, 551–568, 618–632 271–502, 804–1027 38–133, 564–668 719–803, 181–270 Multidrug efflux transporter AcrB transmembrane domain
BCAL2821 ORF4 Chromosome 1 38–134, 445–493, 809–1035, 272–503 8–32, 36–54, 336–359, 363–384, 391–415, 445–468, 470–493, 553–570, 622–636 272–503, 809–1035 38–134, 566–672 182–271, 723–808 Multidrug efflux transporter AcrB transmembrane domain
BCAL1778 ORF5 Chromosome 1 40–136, 446–494, 812–1037, 274–504 10–34, 38–56, 338–361, 365–386, 393–417, 446–469, 471–494, 562–579, 629–643 274–504, 812–1037 40–136, 575–676 184–273, 727–811 Multidrug efflux transporter TolC docking domain
BCAL1079 ORF6 Chromosome 1 40–136, 438–486, 792–1019, 266–496 10–34, 38–56, 330–353, 357–378, 385–409, 438–461, 463–486, 543–560, 610–624 266–496, 792–1019 40–136, 556–656 189–265, 707–791 Multidrug efflux transporter AcrB pore domain
BCAL1080 ORF7 Chromosome 1 40–134, 438–486, 853–1084, 266–496 10–34, 38–56, 330–353, 357–378, 385–409, 438–461, 463–486, 544–561, 607–621 266–496, 853–1084 40–134, 557–653 183–265, 704–776 Multidrug efflux transporter AcrB pore domain
BCAM0926 ORF8 Chromosome 2 38–134, 445–493, 803–1027, 272–503 8–32, 36–54, 336–359, 363–384, 391–415, 445–468, 470–493, 552–569, 619–633 272–503, 803–1027 38–134, 565–667 182–271, 718–802 Multidrug efflux transporter AcrB pore domain
BCAM1946 ORF9 Chromosome 2 40–136, 447–495, 814–1041, 275–505 10–34, 38–56, 339–362, 366–387, 394–418, 447–470, 472–495, 562–579, 631–645 275–505, 814–1041 40–136, 575–678 185–274, 729–813 Multidrug efflux transporter TolC docking domain
BCAM2550 ORF10 Chromosome 2 40–136, 447–495, 817–1043, 275–505 10–34, 38–56, 339–362, 366–387, 394–418, 447–470, 472–495, 562–579, 631–645 275–505, 817–1043 40–136, 575–681 185–274, 732–816 Multidrug efflux transporter AcrB pore domain
BCAM0713 ORF11 Chromosome 2 42–135, 480–503, 822–1049, 167–513 12–36, 40–58, 339–362, 366–387, 480–503, 553–570 167–513, 822–1049 42–135, 566–673 726–821 Multidrug efflux transporter TolC docking domain
BCAM0435 ORF12 Chromosome 2 42–135, 454–502, 807–1043, 269–511 12–36, 40–58, 334–357, 361–382, 389–413, 552–569 269–511, 807–1043 42–135, 565–610 185–268, 722–806 Multidrug efflux transporter AcrB pore domain
BCAL1811 ORF13 Chromosome 1 49–146, 446–494, 805–1029, 274–504 47–65, 339–362, 393–417, 446–469, 471–494, 554–571 274–504, 805–1029 49–146, 567–677 192–273, 721–804 Multidrug efflux transporter AcrB pore domain
BCAS0582 ORF14 Chromosome 3 40–136, 438–486, 832–1060, 266–496 10–34, 38–56, 330–353, 357–378, 385–409, 438–461, 463–486, 551–568 266–496, 832–1060 40–136, 564–675 183–265, 727–831 Multidrug efflux transporter AcrB pore domain

aAs reported by the web site: http://www.sanger.ac.uk/Projects/B_cenocepacia/; bMotifs derived from the BLAST SEARCH program at the web site: http://www.sanger.ac.uk/Projects/B_cenocepacia/; cResults from the web site: http://www.ebi.ac.uk/InterProScan/; dResults from the web site: http://www.sbg.bio.ic.ac.uk/~phyre/.